Blaise Shumate
Blaise Shumate was diagnosed with spinal muscular atrophy, a genetic disorder that affects muscles and movement. He received gene therapy at 3 months with a drug called Zolgensma.
Blaise Shumate was diagnosed with spinal muscular atrophy, a genetic disorder that affects muscles and movement. He received gene therapy at 3 months with a drug called Zolgensma.